论文信息 - Cost-effectiveness of zoledronic acid and strontium-89 as bone protecting treatments in addition to chemotherapy in patients with metastatic castrate-refractory prostate cancer: results from the TRAPEZE trial (ISRCTN 12808747) with - 字舞流文

Cost-effectiveness of zoledronic acid and strontium-89 as bone protecting treatments in addition to chemotherapy in patients with metastatic castrate-refractory prostate cancer: results from the TRAPEZE trial (ISRCTN 12808747) with

S. Beesley | A. Stanley | S. Hussain | I. Goranitis | L. Andronis | J. Wylie | J. Staffurth | D. Barton | S. Pirrie | A. Daunton | Janet E. Brown | O. JoeM. | Russell | J. Martin | A. Pope | P. Chakraborti | Sullivan | C. Parker | Lucinda J. Billingham | Nicholas D. James | Duncan McLaren | S. Collins | A. Birtle